Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multiple sclerosis
Massimo Filippi, Amit Bar‐Or, Fredrik Piehl, et al.
Nature Reviews Disease Primers (2018) Vol. 4, Iss. 1
Closed Access | Times Cited: 1034

Showing 1-25 of 1034 citing articles:

Hallmarks of neurodegenerative diseases
David M. Wilson, Mark Cookson, Ludo Van Den Bosch, et al.
Cell (2023) Vol. 186, Iss. 4, pp. 693-714
Open Access | Times Cited: 769
Astrocyte Crosstalk in CNS Inflammation
Mathias Linnerbauer, Michael A. Wheeler, Francisco J. Quintana
Neuron (2020) Vol. 108, Iss. 4, pp. 608-622
Open Access | Times Cited: 653
Function and therapeutic value of astrocytes in neurological diseases
Hong‐Gyun Lee, Michael A. Wheeler, Francisco J. Quintana
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 5, pp. 339-358
Open Access | Times Cited: 357
Microglia and Central Nervous System–Associated Macrophages—From Origin to Disease Modulation
Marco Prinz, Takahiro Masuda, Michael A. Wheeler, et al.
Annual Review of Immunology (2021) Vol. 39, Iss. 1, pp. 251-277
Open Access | Times Cited: 350
Immune cell regulation of glia during CNS injury and disease
Andrew D. Greenhalgh, Sam David, F. Chris Bennett
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 3, pp. 139-152
Closed Access | Times Cited: 306
B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers
Jamie van Langelaar, Liza Rijvers, Joost Smolders, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 227
Clinical applications of stem cell-derived exosomes
Fei Tan, Xuran Li, Zhao Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 201
Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid
Michael Heming, Xiaolin Li, Saskia Räuber, et al.
Immunity (2020) Vol. 54, Iss. 1, pp. 164-175.e6
Open Access | Times Cited: 158
Rituximab for the treatment of multiple sclerosis: a review
Clara Grazia Chisari, Eleonora Sgarlata, Sebastiano Arena, et al.
Journal of Neurology (2021) Vol. 269, Iss. 1, pp. 159-183
Open Access | Times Cited: 153
Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders
Salman Ul Islam, Adeeb Shehzad, Muhammad Bilal Ahmed, et al.
Molecules (2020) Vol. 25, Iss. 8, pp. 1929-1929
Open Access | Times Cited: 146
Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability
Antonio Carotenuto, Laura Cacciaguerra, Elisabetta Pagani, et al.
Brain (2021) Vol. 145, Iss. 8, pp. 2785-2795
Open Access | Times Cited: 145
Gut Microbiota during Dietary Restrictions: New Insights in Non-Communicable Diseases
Emanuele Rinninella, Marco Cintoni, Pauline Raoul, et al.
Microorganisms (2020) Vol. 8, Iss. 8, pp. 1140-1140
Open Access | Times Cited: 144
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)
Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Therapeutic Advances in Neurological Disorders (2021) Vol. 14
Open Access | Times Cited: 144
Inflammation-related plasma and CSF biomarkers for multiple sclerosis
Jesse Huang, Mohsen Khademi, Lars Fugger, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 23, pp. 12952-12960
Open Access | Times Cited: 143
Adipose Tissue-Derived Mesenchymal Stem Cells
Bruce A. Bunnell
Cells (2021) Vol. 10, Iss. 12, pp. 3433-3433
Open Access | Times Cited: 124
The Glymphatic System (En)during Inflammation
Frida Lind‐Holm Mogensen, Christine Delle, Maiken Nedergaard
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7491-7491
Open Access | Times Cited: 122
How Inflammation Affects the Brain in Depression: A Review of Functional and Structural MRI Studies
Kyu‐Man Han, Byung‐Joo Ham
Journal of Clinical Neurology (2021) Vol. 17, Iss. 4, pp. 503-503
Open Access | Times Cited: 111
γδ T cells: origin and fate, subsets, diseases and immunotherapy
Yi Hu, Qinglin Hu, Yongsheng Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 104
Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion
Massimo Filippi, Maria Pia Amato, Diego Centonze, et al.
Journal of Neurology (2022) Vol. 269, Iss. 10, pp. 5382-5394
Open Access | Times Cited: 95
Slowly Expanding Lesions Predict 9-Year Multiple Sclerosis Disease Progression
Paolo Preziosa, Elisabetta Pagani, Alessandro Meani, et al.
Neurology Neuroimmunology & Neuroinflammation (2022) Vol. 9, Iss. 2
Open Access | Times Cited: 81
High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing–Remitting Multiple Sclerosis
Léorah Freeman, Erin E. Longbrake, Patricia K. Coyle, et al.
CNS Drugs (2022) Vol. 36, Iss. 12, pp. 1285-1299
Open Access | Times Cited: 76
Role of tumor necrosis factor-alpha in the central nervous system: a focus on autoimmune disorders
Natalia Gonzalez Caldito
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 72
Uric acid in health and disease: From physiological functions to pathogenic mechanisms
Shijie Wen, Hiroshi Arakawa, Ikumi Tamai
Pharmacology & Therapeutics (2024) Vol. 256, pp. 108615-108615
Closed Access | Times Cited: 61
Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis
Monica Margoni, Paolo Preziosa, Maria A. Rocca, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 51
Common genetic factors among autoimmune diseases
Adil Harroud, David A. Hafler
Science (2023) Vol. 380, Iss. 6644, pp. 485-490
Closed Access | Times Cited: 45
Page 1 - Next Page

Scroll to top